EU and US officials have finally signed an agreement that allows their drug regulators to rely on each other’s good manufacturing practice inspections conducted within their respective territories.
EU, US Finally Agree On Mutual Recognition Of GMP Inspections
Reliance on each other’s good manufacturing practice reports should allow EU and US regulators to better focus their limited inspection resources on drug manufacturers in other countries around the world.
